Skip to content

Biohaven BHVN Other Working Capital

Other Working Capital at other companies

Eli Lilly logo
Eli LillyLLY
-$175M-137%
uniQure logo
uniQureQURE
$242K-93.9%
Roivant Sciences logo
Roivant SciencesROIV
-$8.3M-230%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$2K-140%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$306K-1,557%
ADMA Biologics logo
ADMA BiologicsADMA
0.3%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's other working capital?
Biohaven (BHVN) reported other working capital of $837K in Q1 2026.
How has Biohaven's other working capital changed year-over-year?
Biohaven's other working capital decreased by 70.6% year-over-year, from $2.84M to $837K.
What is the long-term trend for Biohaven's other working capital?
Over 3 years (2022 to 2025), Biohaven's other working capital has grown at a -37.9% compound annual growth rate (CAGR), from -$726K to -$174K.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.